Related Experiment Videos
Extracorporeal Life Support Organization 1993
C J Stolar1, T Delosh, R H Bartlett
1Extracorporeal Life Support Organization, Ann Arbor, Michigan.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|October 1, 1993
Insights
The Extracorporeal Life Support Organization
Area of Science:
- Critical Care Medicine
- Pediatric Cardiology
- Neonatal Medicine
Background:
- Extracorporeal membrane oxygenation (ECMO) offers life support for severe cardiorespiratory failure.
- The Extracorporeal Life Support Organization (ELSO) registry collects data on ECMO patient outcomes.
- This report details aggregate patient experience up to April 1993.
Purpose of the Study:
- To summarize the outcomes of patients treated with ECMO.
- To analyze survival rates across different patient populations (neonatal, pediatric pulmonary, neonatal/pediatric cardiac).
Main Methods:
- Data compilation from the ELSO registry.
- Analysis of patient demographics and survival statistics.
- Focus on patients with a high predicted mortality risk (≥80%).
Main Results:
- Overall survival rates reported: 81% for neonatal, 48% for pediatric pulmonary, and 45% for neonatal/pediatric cardiac patients.
- These survival rates are presented for patients with a high likelihood of mortality.
- Data reflects aggregate experience as of April 1993.
Conclusions:
- ECMO demonstrates significant survival benefits in critically ill neonates, pediatric, and cardiac patients.
- The findings highlight the effectiveness of ECMO in high-risk patient groups.
- Continued data collection and analysis are crucial for advancing ECMO therapy.
Abstract:
This is the annual report of the Extracorporeal Life Support Organization. It concerns the aggregate experience of all reported patients treated with extracorporeal membrane oxygenation as of April 1993. The patients are either neonatal, pediatric pulmonary, or neonatal/pediatric cardiac. A survival rate of 81% (neonatal), 48% (pediatric), and 45% (cardiac) is reported in patients thought to have at least an 80% mortality likelihood.